Feed

Show only
23/05/2019
Happy Birth­day GDPR in CEE
18/06/2019
Ag­nes Solyom and Katal­in Hor­váth have pro­duced a pa­per look­ing at...
14/06/2019
The EUIPO de­liv­ers its ver­dict on the long­stand­ing dis­pute between...
EUTM Can­cel­la­tion Ac­tion: (1) Pro­mote Ice­land, (2) The Iceland­ic Min­istry for For­eign Af­fairs and (3) SA – Busi­ness Ice­land v. Ice­land Foods Lim­ited. Back­ground Three Iceland­ic au­thor­it­ies (“Iceland­ic Ap­plic­ants”) filed an ap­plic­a­tion for a de­clar­a­tion of in­valid­ity.
Post BEPS in­tel­lec­tu­al prop­erty tax­a­tion
13/06/2019
SPC Man­u­fac­tur­ing Waiver to come in­to ef­fect 1 Ju­ly 2019
Gen­er­ics com­pan­ies will soon be able to man­u­fac­ture SPC-pro­tec­ted drugs for ex­port out­side the EU un­der new man­u­fac­tur­ing waiver pro­vi­sions. In the last six months of the SPC life­time, it will also be al­low­able to man­u­fac­ture gen­er­ics for stock­pil­ing for “day.
CMS Ex­pert Guide to Se­cur­ity Token Of­fer­ings
11/06/2019
CJEU de­cision tight­ens work­ing time reg­u­la­tions
EU em­ploy­ers must now keep de­tailed re­cords of their em­ploy­ees’ work­ing hours, fol­low­ing a re­cent rul­ing by the Court of Justice of the European Uni­on (CJEU). Na­tion­al law­makers face the chal­lenge of en­sur­ing com­pli­ance across di­verse in­dus­tries and vary­ing.
April 2019
Stu­dent Ac­com­mod­a­tion in CEE: the next big thing?
30/05/2019
EPO's strict ap­proach to de­cid­ing if a com­pos­i­tion can be­ne­fit from...
The EPO Tech­nic­al Board of Ap­peal (TBA) re­viewed the law around nov­elty of use, and de­term­ined that in the case of Car­di­oPoly­mer, Inc. 's European pat­ent ap­plic­a­tion (EP07837908. 8), the claimed chem­ic­al en­tity did not qual­i­fy as a 'sub­stance or com­pos­i­tion'.